Visceral leishmaniasis: a lingual presentation in a patient with HIV infection. 1998

T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
Department of Oral Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

The term leishmaniasis covers a series of illnesses caused by the protozoan Leishmania; depending on the patient's immune response, the particular species of the protozoan, and the geography, the condition may manifest itself as cutaneous, mucocutaneous, or visceral disease. Visceral leishmaniasis has often been found as a co-infection associated with the human immunodeficiency virus, particularly in the region of the western Mediterranean. We report the case of an HIV-infected patient with a history of treated laryngeal leishmaniasis who subsequently appeared for treatment with a tumorous lesion on the dorsum of the tongue that was caused by Leishmania infection.

UI MeSH Term Description Entries
D007827 Laryngitis Inflammation of the LARYNGEAL MUCOSA, including the VOCAL CORDS. Laryngitis is characterized by irritation, edema, and reduced pliability of the mucosa leading to VOICE DISORDERS such as APHONIA and HOARSENESS. Laryngitides
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008297 Male Males
D008536 Meglumine 1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. Methylglucamine
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077485 Meglumine Antimoniate ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS. Glucantime,N-Methylglucamine Antimonate,N Methylglucamine Antimonate
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000965 Antimony A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal

Related Publications

T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
April 2013, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
August 1995, Revista clinica espanola,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
February 2001, Revista clinica espanola,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
May 2011, Sultan Qaboos University medical journal,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
September 2014, AIDS research and human retroviruses,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
January 1989, Enfermedades infecciosas y microbiologia clinica,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
February 1995, Enfermedades infecciosas y microbiologia clinica,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
July 1991, Revista clinica espanola,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
April 2010, The Medical journal of Australia,
T Vázquez-Piñeiro, and J M Fernández Alvarez, and J C Gonzalo Lafuente, and J Cano, and M Gimeno, and J Berenguer
April 1994, European journal of pediatrics,
Copied contents to your clipboard!